Peter Comerford

HYTN Innovations Inc. (CSE:HYTN) has successfully sold cannabis flower to serve the Australian medical cannabis market under the Promethean BioPharma brand pursuant to the company’s supply agreement with TCann Pty Ltd. “HYTN is focused on innovating at all levels within the cannabis...